Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers

Introduction: Linezolid is a last-resort antibiotic for infections caused by multidrug-resistant microorganisms. It is widely used for off-label indications and for longer than recommended treatment durations, exposing patients at higher risk of adverse drug reactions (ADRs), notably thrombocytopeni...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Hélène Thirot, David Fage, Antonia Leonhardt, Philippe Clevenbergh, Tatiana Besse-Hammer, Jean Cyr Yombi, Olivier Cornu, Caroline Briquet, Maya Hites, Frédérique Jacobs, Gert-Jan Wijnant, Sebastian G. Wicha, Frédéric Cotton, Paul M. Tulkens, Anne Spinewine, Françoise Van Bambeke
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2024-01-01
Saila:	Frontiers in Pharmacology
Gaiak:	linezolid thrombocytopenia adverse drug reaction therapeutic drug monitoring anemia Buzelé score
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1310309/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!